Some 17 months ago, scientists detected an outbreak of highly pathogenic H5N1 avian influenza in dairy cattle in Nebraska in ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Nipah virus does not just infect the body, it disrupts immune defences at multiple levels, suppressing early antiviral responses and triggering harmful inflammation.

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold becomes.

Nipah virus in India poses a serious threat due to immune suppression, rapid spread, brain involvement, and high fatality rates despite early recovery signs.

How does the body react after contracting the deadly NiV? Expert explains how the Nipah virus attacks the brain, leading to ...

In a quiet freshwater pond in Ibaraki Prefecture near Tokyo, researchers have pulled from the water a microscopic giant that ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...